These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15757851)

  • 1. Effects of levothyroxine treatment on biochemical and hemostasis parameters in patients with hypothyroidism.
    Gullu S; Sav H; Kamel N
    Eur J Endocrinol; 2005 Mar; 152(3):355-61. PubMed ID: 15757851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the respective influence of thyroid hormones and TSH on blood coagulation parameters after total thyroidectomy.
    Yango J; Alexopoulou O; Eeckhoudt S; Hermans C; Daumerie C
    Eur J Endocrinol; 2011 Apr; 164(4):599-603. PubMed ID: 21257724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of Hemostatic Parameters in Patients with Different Levels of Subclinical Hypothyroidism and the Effect of L-thyroxine Treatment.
    Gao F; Wang G; Xu J
    Ann Clin Lab Sci; 2017 Jan; 47(1):29-35. PubMed ID: 28249913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered platelet plug formation in hyperthyroidism and hypothyroidism.
    Homoncik M; Gessl A; Ferlitsch A; Jilma B; Vierhapper H
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3006-12. PubMed ID: 17488803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute desmopressin and of long-term thyroxine replacement on haemostasis in hypothyroidism.
    Erfurth EM; Ericsson UB; Egervall K; Lethagen SR
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):373-8. PubMed ID: 7750191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition.
    Teixeira PF; Cabral MD; Silva NA; Soares DV; Braulio VB; Couto AP; Henriques JL; Costa AJ; Buescu A; Vaisman M
    Thyroid; 2009 May; 19(5):443-50. PubMed ID: 19415994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy.
    Abalovich M; Vázquez A; Alcaraz G; Kitaigrodsky A; Szuman G; Calabrese C; Astarita G; Frydman M; Gutiérrez S
    Thyroid; 2013 Nov; 23(11):1479-83. PubMed ID: 23731335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid profile and lipoprotein (a) as a risk factor for cardiovascular disease in women with subclinical hypothyroidism.
    Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ; Ozden M
    Endocr Res; 2003 Aug; 29(3):307-16. PubMed ID: 14535632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism.
    Çatlı G; Anık A; Ünver Tuhan H; Böber E; Abacı A
    J Clin Res Pediatr Endocrinol; 2014 Dec; 6(4):238-44. PubMed ID: 25541895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism.
    Duntas LH; Mantzou E; Koutras DA
    Thyroid; 2002 Nov; 12(11):1003-7. PubMed ID: 12490078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary and Secondary Hemostasis in Patients With Subclinical Hypothyroidism: Effect of Levothyroxine Treatment.
    Lupoli R; Di Minno MN; Tortora A; Scaravilli A; Cacciapuoti M; Barba L; Di Minno A; Ambrosino P; Lupoli GA; Lupoli G
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2659-65. PubMed ID: 25955227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of overt and subclinical hypothyroidism. Factors influencing L-thyroxine dosage.
    Rezzónico JN; Pusiol E; Saravi FD; Rezzónico M; Bossa N
    Medicina (B Aires); 1999; 59(6):698-704. PubMed ID: 10752211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in von Willebrand factor and carotid intima-media thickness in hypothyroid patients with normal thyroid function after levothyroxine replacement therapy.
    Nagasaki T; Inaba M; Henmi Y; Kumeda Y; Ueda M; Tahara H; Ishimura E; Onoda N; Ishikawa T; Nishizawa Y
    Eur J Endocrinol; 2004 Feb; 150(2):125-31. PubMed ID: 14763909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levothyroxine Replacement in Obese Adults: The Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities.
    Mele C; Tagliaferri MA; Pagano L; Soranna D; Scacchi M; Aimaretti G; Biondi B; Marzullo P
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6265-6274. PubMed ID: 31265068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
    Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
    Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
    Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
    Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical hypothyroidism and cardiovascular risk: a reason to treat?
    Palmieri EA; Fazio S; Lombardi G; Biondi B
    Treat Endocrinol; 2004; 3(4):233-44. PubMed ID: 16026106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of levothyroxine replacement therapy on coagulation and fibrinolysis in severe hypothyroidism.
    Chadarevian R; Jublanc C; Bruckert E; Giral P; Ankri A; Leenhardt L; Chapman J; Turpin G
    J Endocrinol Invest; 2005 May; 28(5):398-404. PubMed ID: 16075920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.